NCT05889338
Effect of Adalimumab Therapy on Psoriasis Patient treatment Not Available not_yet_recruiting NCT06592274
A Phase 2 Study to Explore the Efficacy and Safety of HB0017 Longer Dose Interval in Psoriasis Patients No drug interventions treatment 2 not_yet_recruiting NCT03456206
Chronic Inflammatory Disease, Lifestyle and Risk of Disease No drug interventions Not Available Not Available unknown_status NCT06620692
A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients with Psoriasis No drug interventions treatment 2 not_yet_recruiting NCT04433442
Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis No drug interventions Not Available Not Available recruiting NCT04630652
Risankizumab Long-term Remission Study treatment 4 active_not_recruiting NCT06247319
Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in Greece No drug interventions Not Available Not Available recruiting NCT04728165
Anti-Inflammatory Effects of Time-Restricted Feeding No drug interventions Not Available Not Available completed NCT04864886
Metabolic Profiling of Immune Responses in Immune-mediated Diseases No drug interventions Not Available Not Available recruiting NCT05111210
Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis No drug interventions Not Available Not Available recruiting NCT05500794
Meditation in Inflammatory Dermatosis No drug interventions other Not Available recruiting NCT05655299
VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis No drug interventions treatment 2 terminated NCT05730725
A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis No drug interventions treatment 2 completed NCT06610890
Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate Tablets treatment 1 not_yet_recruiting NCT06610903
Bioequivalence Test of Hemay005 Tablets No drug interventions other 1 not_yet_recruiting NCT06610942
Characterization of the Fungal Immunopeptidome Involved in the Immunopathological Mechanisms of Psoriasis No drug interventions Not Available Not Available not_yet_recruiting NCT06398652
Comparative Study of CMAB015 and Secukinumab for Patients With Moderate to Severe Plaque Psoriasis treatment 3 recruiting NCT06588283
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight treatment 3 not_yet_recruiting NCT06599411
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases No drug interventions Not Available Not Available not_yet_recruiting NCT00002143
Treatment of Psoriasis Using Acitretin in HIV-Positive Patients treatment 3 completed NCT00096603
A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g treatment 3 completed NCT03302390
Role of Chemokine and Chemokine Receptor in Psoriasis No drug interventions Not Available Not Available withdrawn NCT04894890
A Prospective Multicenter Study for the Assessment of Treatment Patterns, Effectiveness and Safety of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis in a Real-world Setting in China Not Available Not Available completed NCT03198390
Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions No drug interventions Not Available Not Available terminated NCT03453190
Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis treatment 4 unknown_status NCT01208090
ACT-128800 in Patients With Moderate to Severe Chronic Plaque Psoriasis treatment 2 completed NCT01187264
Dose Ranging Study to Compare the Efficacy and Safety of Methotrexate in Plaque Type Psoriasis treatment 4 completed NCT01782664
A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis No drug interventions treatment 2 completed NCT02180464
A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis No drug interventions treatment 2 completed NCT05096364
A Phase 2 Study of Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis No drug interventions treatment 2 completed NCT05633264
A Study to Assess Deucravacitinib Post-marketing Surveillance in Participants With Psoriasis in Japan No drug interventions Not Available Not Available recruiting NCT01098721
A Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeks treatment 2 completed NCT01313221
Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis treatment 3 completed NCT03622021
A Study of AK111 in Healthy Subjects No drug interventions other 1 completed NCT01011621
Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis treatment 3 unknown_status NCT05718921
A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers No drug interventions treatment 1 completed NCT06357221
A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients treatment 4 active_not_recruiting NCT03048721
Skin Tape Harvesting for Transcriptomics Analysis No drug interventions other Not Available completed NCT01083121
Surveillance of Humira Injection in Korean Patients No drug interventions Not Available Not Available completed NCT05758402
A Randomized, Open, Parallel, Controlled, Multi-center, Interventional, Cross-sectional Study to Evaluate the Detection Rate of Psoriatic Arthritis in Korean Moderate-to-severe Psoriasis Patients, With or Without Active Screening for Arthritis in Psoriasis (ASAP Study) No drug interventions diagnostic Not Available completed NCT01604902
miRNAs and mRNAs in Psoriasis No drug interventions Not Available Not Available unknown_status NCT03941184
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity No drug interventions Not Available Not Available completed NCT00368784
T Cell Repertoire Analysis of Immune Mediated Skin Diseases No drug interventions Not Available Not Available completed NCT00930384
A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis No drug interventions Not Available Not Available completed NCT03768284
Genetic Analysis of Pediatric Psoriasis No drug interventions Not Available Not Available completed NCT03718884
A Study of Mirikizumab in Participants With Plaque Psoriasis basic_science 1 completed NCT01714284
Efficacy Study of Dietary Intervention and Weight Loss in Improving Psoriasis No drug interventions treatment Not Available completed NCT01382784
Psoriasis and the Risk of Cardiovascular Disease. A Prospective Study No drug interventions Not Available Not Available unknown_status NCT04099979
A Pilot Study to Explore the Role of Gut Flora in Psoriasis No drug interventions Not Available Not Available unknown_status NCT03284879
Post-Marketing Surveillance Study of OTEZLA No drug interventions Not Available Not Available completed NCT04711343
Comparative Study to Evaluate the Pharmacokinetics of BAT2306 vs Cosentyx® in Healthy Subjects treatment 1 completed NCT01169987
Evaluation of Humira Retention Rate in Psoriasis Patients in Daily Practice and Assessment of Work Productivity and Quality of Life No drug interventions Not Available Not Available completed NCT04841187
Assessing the Long Term Effectiveness and Safety of Systemic Treatments in Cutaneous Psoriasis No drug interventions Not Available Not Available completed NCT01484587
A Study of the Safety, Tolerability, Pharmacokinetics (What the Body Does to the Drug), and Pharmacodynamics (What the Drug Does to the Body) of CNTO 1959 Following a Single Subcutaneous (Under the Skin) Administration in Japanese Participants With Moderate to Severe Plaque Psoriasis treatment 1 completed NCT01368887
Study to Test the Effectiveness of a New Treatment for Scalp Psoriasis treatment 2 suspended NCT04316533
Work Stress and Impact of Pruritus on Quality of Life No drug interventions Not Available Not Available completed NCT01993433
A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis No drug interventions treatment 2 completed NCT01624233
A Study in Japanese Participants With Moderate-to-Severe Psoriasis treatment 3 completed NCT02951533
A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT05252533
A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis other 1 completed NCT01947933
A Safety Study of Mirikizumab (LY3074828) basic_science 1 completed NCT01585233
A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis treatment 2 completed NCT05399433
Role of Glucose Metabolism in Migration of Cutaneous Dendritic Cells in Psoriasis No drug interventions other Not Available recruiting NCT01745133
Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis treatment 4 completed NCT00338754
Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis treatment 2 / 3 completed NCT05683054
A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients Who Are Overtreated treatment 4 completed NCT04039451
Prevalence of Psoriasis and Vitiligo in Assiut Governorate, Egypt No drug interventions Not Available Not Available unknown_status NCT02047851
Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis No drug interventions treatment Not Available terminated NCT01510951
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis No drug interventions basic_science 1 completed NCT03611751
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis treatment 3 completed NCT05555953
Effect of Long-term Psoriasis on Patients' Life - CORONATE No drug interventions Not Available Not Available recruiting NCT00842153
Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam treatment 4 completed NCT02305953
Cytokines and Vascular Inflammation in Psoriasis No drug interventions Not Available Not Available completed NCT02209753
BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis treatment 2 completed NCT01873677
Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis treatment 3 completed NCT02458677
Single Ascending Dose Study of PRX003 in Healthy Subjects No drug interventions treatment 1 completed NCT03506477
Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color treatment 4 completed NCT00894777
Study Evaluating Management of Patients With Moderate and Severe Psoriasis No drug interventions Not Available Not Available completed NCT04372277
Taltz in Combination With Enstilar for Psoriasis treatment 4 recruiting NCT00971477
Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of Psoriasis No drug interventions health_services_research 2 completed NCT00156247
Acitretin and Etanercept in Psoriasis treatment 2 completed NCT05590247
Role of Intermittent Fasting in Psoriasis and Psoriatic Arthritis No drug interventions treatment Not Available recruiting NCT00106847
A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis treatment 3 completed NCT01276847
A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206) treatment 1 completed NCT02908347
Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients No drug interventions treatment 2 completed NCT04513847
PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis No drug interventions Not Available Not Available completed NCT00508547
Psoriasis Longitudinal Assessment and Registry No drug interventions Not Available Not Available active_not_recruiting NCT01856647
Pilot Study Characterizing Adipose Tissue Leukocytes by Flow Cytometry/Microscopy in Lean, Obese and Psoriatic Subjects No drug interventions Not Available Not Available terminated NCT03080545
Enstilar in Combination With Biologic Agents treatment 4 completed NCT03022045
A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis treatment 3 completed NCT03737045
Psoriatic Arthritis and Psoriasis Treatment Decision Aid No drug interventions other Not Available active_not_recruiting NCT03384745
A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis treatment 2 completed NCT05796245
A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis No drug interventions Not Available Not Available completed NCT02929745
Single Cell Genomics of Psoriatic Skin No drug interventions basic_science Not Available completed NCT05589298
The Study of Koebner in Patients With Psoriasis and Psoriatic Arthritis No drug interventions Not Available Not Available recruiting NCT05604898
A Phase 2 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis No drug interventions treatment 2 active_not_recruiting NCT02718898
A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis treatment 3 completed NCT06482398
Cream Containing Sericin and Turmeric in Psoriasis Patients treatment Not Available not_yet_recruiting NCT02999698
Patients With Hidradenitis vs Patients With Psoriasis: Psychological Impact No drug interventions Not Available Not Available unknown_status NCT00384098
Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis treatment 2 completed NCT02655705
Comparison Study of Psoriasis Severity Assessment Tools treatment 4 completed NCT05943405
The Disease Severity In Patients With Psoriasis No drug interventions Not Available Not Available completed NCT01901705
A Study of Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type Psoriasis treatment 2 completed NCT06021405
Koebner's Phenomenon in Psoriasis and Lichen Planus No drug interventions basic_science Not Available not_yet_recruiting NCT02701205
Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis treatment 3 unknown_status NCT00645905
Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis treatment 2 completed NCT04106297
A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3970 No drug interventions basic_science 1 completed NCT00001797
Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis treatment 2 completed NCT05555797
Excimer Laser With Topical Agents in Psoriasis Vulgaris treatment 4 not_yet_recruiting NCT01527097
Influence of Atorvastatin on Psoriasis Severity and Endothelial Function treatment 3 withdrawn NCT02576197
Intervention Study to Evaluate a Probiotic in Mild to Moderate Psoriasis Patients No drug interventions supportive_care Not Available completed NCT01991197
Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial. treatment 2 completed NCT02075697
Spanish Registry of Systemic Treatments in Psoriasis No drug interventions Not Available Not Available recruiting NCT06301997
A Herbal Compound for Psoriasis No drug interventions treatment 2 active_not_recruiting NCT06555497
Topical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With Psoriasis basic_science 0 completed NCT04995783
Predicting Medication Response for Autoimmune Disease No drug interventions Not Available Not Available terminated NCT00050661
To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris treatment 1 / 2 completed NCT00638261
Primary UVB-311nm and Adalimumab in Psoriasis Patients No drug interventions treatment Not Available completed NCT00759161
Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis treatment 2 completed NCT02103361
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project Not Available Not Available recruiting NCT01465061
A Survey on the Role and Benefits of Online Social Networks on Filipino Patients With Psoriasis No drug interventions Not Available Not Available completed NCT01133561
Pioglitazone in Psoriasis- A Clinical and Molecular Study. No drug interventions treatment Not Available completed NCT00678561
Topical CP-690,550 For Chronic Plaque Psoriasis treatment 2 completed NCT00723528
An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis treatment 3 completed NCT04839328
A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis No drug interventions treatment 3 completed NCT01848028
PsoBest - The German Psoriasis Registry No drug interventions Not Available Not Available recruiting NCT03531528
Aggressive Weight Loss Program in Chronic Plaque Psoriasis No drug interventions treatment Not Available completed NCT00096928
A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE) No drug interventions Not Available Not Available completed NCT03483311
Resolvin D1 in Psoriasis Before and After Narrowband UVB Phototherapy No drug interventions diagnostic Not Available unknown_status NCT02713711
Effectiveness of Artificial Balneotherapy, Phototherapy and Artificial Balneophototherapy in the Treatment of Psoriasis No drug interventions treatment Not Available completed NCT03482011
A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis treatment 3 completed NCT03409211
Patterns After Administration of MCFAs in Psoriasis and Psoriatic Arthritis No drug interventions treatment Not Available completed NCT04811911
Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum TWEAK Level in Psoriasis treatment 4 unknown_status NCT03418493
A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis No drug interventions basic_science 1 completed NCT01702493
A Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male Volunteers other 1 completed NCT00684593
A Study to Assess the Clinical Effects of Navarixin in Participants With Psoriasis (MK-7123-009) treatment 2 completed NCT04750993
Comparison of the Frequency of Subclinic Synovitis in the Distal Interphalangeal Joints of the Hand in Psoriasis Patients No drug interventions Not Available Not Available completed NCT01320293
Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab. treatment Not Available completed NCT02271971
Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis No drug interventions treatment Not Available completed NCT00001371
A Pilot Study of Topical Antiflammin-2 for Psoriasis No drug interventions Not Available Not Available completed NCT01948271
Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis No drug interventions treatment 1 terminated NCT05770271
The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and Psoriasis No drug interventions treatment Not Available completed NCT05883371
IMPACT - AndHealth Autoimmune Research Registry No drug interventions Not Available Not Available recruiting NCT04423471
Neuroinflammation, Affective and Cognitive Symptoms in Major Depression and Psoriasis No drug interventions Not Available Not Available withdrawn NCT03123471
A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp treatment 3 completed NCT06061471
To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis No drug interventions treatment 2 recruiting NCT00555178
Regulatory T Cells (Tregs) in Polymorphic Light Eruption No drug interventions Not Available Not Available completed NCT03580278
A Study to Investigate the Safety, Tolerability, Pharmacokinetic, and Efficacy of ABY-035/AFO2 treatment 1 completed NCT02376478
On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection Not Available Not Available completed NCT00929578
Fluphenazine Hydrochloride for Psoriasis treatment 2 completed NCT01970488
Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT06230588
A Clinical Trial of TQH3906 Capsules in Healthy Volunteers No drug interventions treatment 1 recruiting NCT00658788
Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis treatment 3 completed NCT02191007
Efficacy and Safety Study of Calcipotriol Betamethasone Plus Calcipotriol in Sequential Therapy to Psoriasis treatment Not Available completed NCT04555707
The Maintenance Effect of Enstilar Foam in Combination With Otezla treatment 4 unknown_status NCT00341809
Genetic Analysis of Psoriasis and Psoriatic Arthritis No drug interventions Not Available Not Available completed NCT02303509
Study to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriatic Subject basic_science 1 completed NCT00427609
Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications treatment 2 terminated NCT02555709
An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients No drug interventions treatment 1 / 2 completed NCT01987609
Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques treatment 2 completed NCT01961609
Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants. treatment 3 completed NCT05461456
Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% treatment 1 completed NCT04371185
Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects treatment 1 completed NCT01700985
A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis No drug interventions treatment 2 completed NCT02872285
An Efficacy and Safety Study of LYC-30937-EC in Subjects With Moderate Chronic Plaque-type Psoriasis No drug interventions treatment 2 completed NCT02785185
Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis treatment 2 completed NCT01511315
The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment treatment 4 completed NCT01952015
Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP) treatment 3 completed NCT04904315
Subjects Through the Application of the Mindera Kit Part 2 No drug interventions Not Available Not Available unknown_status NCT00129415
Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions No drug interventions treatment 1 / 2 terminated NCT03873415
Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males treatment 1 completed NCT01539915
Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients No drug interventions Not Available 1 completed NCT00954915
Safety Study of the Monoclonal Antibody Teplizumab (MGA031) in Subjects With Moderate or More Severe Psoriasis treatment 1 / 2 terminated NCT00121615
Study of Etanercept in the Treatment of Psoriasis in Adult Subjects treatment 3 completed NCT00835315
Prevalence of Psoriasis Alba in Psoriatic Patients No drug interventions Not Available Not Available unknown_status NCT01782937
An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis treatment 3 completed NCT04533737
Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab treatment 4 terminated NCT00975637
Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis treatment 2 completed NCT01309737
A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis treatment 3 completed NCT00332332
Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis treatment 4 completed NCT01582932
Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis treatment 1 completed NCT03492632
Ovarian Reserve in Patients With Psoriasis No drug interventions Not Available Not Available completed NCT02075632
Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream treatment 2 completed NCT06043752
Efficacy and Safety of Infliximab Biosimilar Remsima in Psoriasis treatment 4 completed NCT02672852
BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment treatment 3 completed NCT03927352
The Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque Psoriasis treatment 3 unknown_status NCT02548052
Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis treatment 1 completed NCT00725452
Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900) Not Available Not Available completed NCT01019200
Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis No drug interventions Not Available Not Available completed NCT01101100
Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis treatment 2 terminated NCT01177800
A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis treatment 3 completed NCT00356200
Fluphenazine Decanoate for Psoriasis treatment 2 terminated NCT02147600
Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients No drug interventions Not Available Not Available completed NCT00647400
Adalimumab in Adult Japanese Subjects With Psoriasis treatment 2 / 3 completed NCT05098600
The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic No drug interventions Not Available Not Available completed NCT00778700
A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis treatment 2 completed NCT04435600
A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms treatment 3 active_not_recruiting NCT02808559
PASIMAT: Automatic Measure of PASI No drug interventions diagnostic Not Available completed NCT02503059
Etanercept Survival in Elderly Population No drug interventions Not Available Not Available completed NCT06275659
An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis No drug interventions basic_science Not Available active_not_recruiting NCT01984775
A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects treatment 1 completed NCT00779675
Assessment of Long-Term Infliximab for Psoriasis (P05319) Not Available Not Available completed NCT05503875
Immunoclassification of Psoriasis: a Strategy for Precision Medicine treatment Not Available recruiting NCT00006275
Study of Topical Calcitriol in Children With Psoriasis treatment Not Available completed NCT03000075
BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis treatment 2 completed NCT02698475
An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age treatment 3 completed NCT05959070
An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO) No drug interventions Not Available Not Available active_not_recruiting NCT00358670
Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563) treatment 3 terminated NCT01429870
Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in Psoriasis treatment 4 withdrawn NCT00513370
A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis treatment 3 completed NCT00987870
Safety and Efficacy of BFH772 in Psoriasis Patients treatment 1 / 2 completed NCT04074070
Prevalence of Sonographic Abnormalities of Joints and Entheses in Psoriasis Patients With or Without Musculoskeletal Complains No drug interventions Not Available Not Available completed NCT05632042
Response of Metabolic Syndrome and Sexual Dysfunction to Lifestyle Changes in Men With Psoriasis No drug interventions treatment Not Available recruiting NCT01538342
Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in Psoriasis No drug interventions basic_science Not Available completed NCT00244842
Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis treatment 3 completed NCT05453942
A Study to Investigate Safety, Tolerability and Clinical Response With SAR441566 Compared With Placebo in Participants With Mild to Moderate Psoriasis No drug interventions treatment 1 completed NCT01235442
Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT00113542
A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris treatment 2 completed NCT01039142
Dose Ranging Study to Assess the Efficacy and Safety of Acitretin in Severe Plaque Type Psoriasis treatment 4 completed NCT05478499
Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis treatment 4 active_not_recruiting NCT00317499
Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis prevention 3 completed NCT02111499
Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test No drug interventions treatment 1 / 2 completed NCT06055699
Association Between the Occurrence of a Clinical RElapse and Gut MIcrobiota Modifications: a Cohort Study of Patients With pSOriasis No drug interventions Not Available Not Available not_yet_recruiting NCT01704599
Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque Psoriasis treatment 1 / 2 terminated NCT05858099
The Early Detection and Progression of Subclinical Atherosclerosis in Psoriasis No drug interventions Not Available Not Available active_not_recruiting NCT04535999
Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV) treatment 4 recruiting NCT04071106
Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial treatment 2 / 3 unknown_status NCT00399906
A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis treatment 2 completed NCT06281106
TYK2 Inhibition in Paradoxical Psoriasis treatment 2 / 3 not_yet_recruiting NCT01988506
Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases No drug interventions treatment 2 completed NCT06101706
Assessment of Fatigue in Psoriatic Arthritis and Cutaneous Psoriasis Patients No drug interventions other Not Available recruiting NCT01920906
Comparative Analysis of Small and Large Plaque Psoriasis No drug interventions basic_science Not Available completed NCT00111449
Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis treatment 3 completed NCT01947036
T and B Cell Responses in Autoimmune Diseases No drug interventions Not Available Not Available terminated NCT00111436
Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects treatment 3 completed NCT03403036
Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies treatment 4 completed NCT02985736
Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray treatment 4 completed NCT03334136
The Effect of Vitamin D Supplementation on Psoriasis Severity treatment Not Available completed NCT03777436
An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis treatment 3 completed NCT00782613
Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis No drug interventions treatment 2 terminated NCT01657513
TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis treatment Not Available unknown_status NCT01504113
The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis No drug interventions Not Available Not Available unknown_status NCT00258713
A 36-Week Extension to Protocol ISA04-03 treatment 3 completed NCT03757013
A Study to Assess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in France Not Available Not Available completed NCT01493518
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With Psoriasis No drug interventions basic_science 1 terminated NCT03062618
A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis No drug interventions treatment 1 completed NCT01247818
Randomized Study of PH-10 for Psoriasis treatment 2 completed NCT01617018
Assessing the Long Term Effectiveness and Safety of Biotherapies in the Treatment of Cutaneous Psoriasis No drug interventions Not Available Not Available completed NCT00287118
A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis treatment 4 completed NCT00236119
Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis treatment 2 completed NCT03768219
Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis No drug interventions treatment 1 terminated NCT00143819
Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis No drug interventions treatment 2 terminated NCT06073119
A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis No drug interventions treatment 2 recruiting NCT00078819
Etanercept (Enbrel®) in Psoriasis - Pediatrics treatment 3 completed NCT00688519
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies No drug interventions treatment 3 completed NCT05190419
Study to Assess the Efficacy and Safety of Orismilast in Psoriasis treatment 2 completed NCT02193919
A Single-Center, Prospective, Pilot Study to Compare the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy No drug interventions Not Available Not Available completed NCT01053819
Can We Miss Pigmented Lesions in Psoriasis Patients? treatment 4 completed NCT05252741
Levels of Pigment Epithelium-derived Factor in Patients With Psoriasis. No drug interventions screening Not Available unknown_status NCT00395941
Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis treatment 2 completed NCT00251641
The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED) treatment 3 completed NCT02538341
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) prevention 2 completed NCT06257641
Impact of the Mediterranean Diet on Patients With Psoriasis No drug interventions treatment Not Available recruiting NCT03440541
Uses of Gamma Irradiated Amniotic Membrane as an Alternative Method in Psoriasis Treatment No drug interventions treatment Not Available completed NCT00026741
Research in Skin Inflammation No drug interventions Not Available Not Available completed NCT00109317
A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy treatment 3 completed NCT03022617
A Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis treatment 4 completed NCT01094717
Acitretin or Tazarotene Gel and Excimer Laser for Treatment of Psoriasis treatment Not Available terminated NCT05480917
Value Based Healthcare in Psoriasis No drug interventions health_services_research Not Available recruiting NCT03745417
Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis No drug interventions treatment 1 / 2 unknown_status NCT00830817
Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis No drug interventions Not Available Not Available completed NCT03816917
Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral No drug interventions Not Available Not Available completed NCT06027034
Effectiveness of a Digital Health Application for Psoriasis No drug interventions treatment Not Available recruiting NCT00333034
Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Psoriasis treatment 3 completed NCT01018134
Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study treatment 2 completed NCT03217734
MAP Study: Methotrexate and Adalimumab in Psoriasis treatment 2 / 3 completed NCT01100034
Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis Not Available Not Available completed NCT03820934
FibroScan ® Study: Assessing Liver Fibrosis in Patients Using Methotrexate for Psoriasis No drug interventions screening Not Available withdrawn NCT00697034
Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin treatment 4 terminated NCT05044234
A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis treatment 2 terminated NCT01815424
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis treatment 3 completed NCT02829424
Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis treatment 4 active_not_recruiting NCT04680624
Role of Brodalumab in the Modulation of Gut Microbiome in Psoriatic Patients No drug interventions basic_science Not Available unknown_status NCT00563524
Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis treatment 1 completed NCT02618616
A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis No drug interventions treatment 2 completed NCT00320216
A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis treatment 2 completed NCT04780516
Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care No drug interventions Not Available Not Available completed NCT02795416
Assessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish Population treatment 3 withdrawn NCT00755196
Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis treatment 2 completed NCT01736696
Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis treatment 1 completed NCT03465696
A Priming Intervention to Increase Patient Willingness to Use Injectables for the Management of Psoriasis No drug interventions health_services_research Not Available active_not_recruiting NCT01006096
Erlotinib for Treatment of Psoriasis treatment 2 withdrawn NCT01356758
Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents Not Available Not Available completed NCT01553058
Vascular Inflammation in Psoriasis Trial (The VIP Trial) treatment 4 completed NCT00762658
A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test treatment 1 completed NCT04190758
GOTHA - The Early Arthritis and Psoriasis Study of Region Västra Götaland, Sweden No drug interventions Not Available Not Available enrolling_by_invitation NCT05185258
Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study basic_science 4 active_not_recruiting NCT06329258
Combination of Sotyktu and Enstilar for Plaque Psoriasis treatment 4 completed NCT04036435
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis treatment 3 active_not_recruiting NCT05283135
High Dose Risankizumab for Psoriasis treatment 2 completed NCT02801435
Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis treatment 1 completed NCT00371163
Molecular and Cellular Characterization of Spongiotic Dermatitis No drug interventions Not Available Not Available completed NCT02748863
Study of Secukinumab With 2 mL Pre-filled Syringes treatment 3 completed NCT04744363
Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab) treatment 1 completed NCT00002286
A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive Patients treatment Not Available completed NCT04673786
A Study to Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque Psoriasis treatment 3 completed NCT02622386
The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis treatment 2 completed NCT00686686
Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED) treatment 3 completed NCT04862286
Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977 treatment 3 enrolling_by_invitation NCT01119339
Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis No drug interventions treatment 2 completed NCT04971239
Topical Methotrexate Microemulsion in the Treatment of Plaque Psoriasis treatment 4 unknown_status NCT01276639
A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis treatment 3 completed NCT03988439
A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis No drug interventions treatment 4 recruiting NCT01836939
Safety and Effectiveness of CNDO 201Trichuris Suis Ova (TSO) for the Treatment of Moderate to Severe Plaque Psoriasis No drug interventions treatment 1 completed NCT03343639
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis treatment 2 completed NCT00293722
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists Not Available Not Available completed NCT02313922
Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate No drug interventions treatment 4 completed NCT00001422
A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis treatment 2 completed NCT03337022
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis No drug interventions treatment 1 completed NCT00566722
Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy treatment 3 completed NCT02559622
Evaluation of Cardiovascular Risk Markers in Psoriasis Patients Treated With Secukinumab treatment 3 completed NCT00377325
The Effectiveness of Lower Cyclosporine Doses for Psoriasis treatment 2 withdrawn NCT03971825
A Safety Study of CC-92252 in Healthy Adult Subjects and Adult Subjects With Psoriasis No drug interventions treatment 1 terminated NCT03381625
Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis No drug interventions treatment 2 completed NCT00235625
Curcuminoids for the Treatment of Chronic Psoriasis Vulgaris No drug interventions treatment 2 completed NCT00295425
CYA Versus MMF for Treatment of Moderate-Severe Psoriasis. treatment 2 unknown_status NCT00162825
Role of CD7 in Skin Inflammation and Psoriasis No drug interventions Not Available Not Available completed NCT06066125
A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Moderate to Severe Plaque Psoriasis No drug interventions treatment 3 active_not_recruiting NCT02602925
Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity No drug interventions treatment 4 completed NCT00550030
Etanercept Plus UVB-311nm Phototherapy in Psoriasis No drug interventions treatment Not Available completed NCT06050330
CD4+ T Cells and S100A7 Epression in Normal and Psoriatic Skin: A Histological and Histochemical Study No drug interventions diagnostic Not Available not_yet_recruiting NCT00150930
Home UVB Phototherapy for Psoriasis: Effectiveness, Quality of Life and Cost-Effectiveness No drug interventions treatment 4 unknown_status NCT03865030
The Inner Ear Function in Psoriatic Patients No drug interventions diagnostic Not Available completed NCT01137448
The Effect of Weight Loss on Psoriasis Area Severity Index in Adult Psoriasis Patients No drug interventions treatment Not Available withdrawn NCT00725348
An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis treatment 2 completed NCT02165657
Excimer Laser, Serum Markers & Psoriasis No drug interventions treatment Not Available withdrawn NCT03765957
Clinical Research on Treatment of Psoriasis by Human Umbilical Cord-derived Mesenchymal Stem Cells No drug interventions treatment 0 unknown_status NCT02684357
BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis treatment 3 completed NCT05125757
Lifestyle Modification in Psoriatic Patients With Fatty Liver No drug interventions treatment Not Available unknown_status NCT04792957
JAK-STAT Signaling Pathway in Pyoderma Gangrenosum No drug interventions Not Available Not Available unknown_status NCT02144857
Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis treatment 4 recruiting NCT04439526
A Study of Guselkumab in Naive or Bio-experienced Participants With Regional (Facial and Genital) Psoriasis Not Available Not Available completed NCT05536726
A Phase 3 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis No drug interventions treatment 3 recruiting NCT00443326
AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects treatment 2 completed NCT03180866
Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis No drug interventions treatment Not Available unknown_status NCT05744466
A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis Not Available Not Available recruiting NCT06416566
Low-Dose Enoxaparin in Psoriasis treatment Not Available not_yet_recruiting NCT03661866
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC No drug interventions Not Available Not Available recruiting NCT02156466
Multiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis Subjects treatment 1 completed NCT05635266
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives No drug interventions Not Available Not Available recruiting NCT00131066
Long-Term Follow-Up Study of Psoriasis Patients No drug interventions Not Available Not Available completed NCT01435265
Nurse Education in Subjects With Psoriasis Undergoing Treatment With Adalimumab No drug interventions health_services_research Not Available completed NCT02850965
Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis treatment 3 completed NCT05144165
Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines No drug interventions Not Available Not Available unknown_status NCT02295865
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis treatment 2 completed NCT02652065
Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis No drug interventions basic_science Not Available completed NCT01088165
The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis prevention 4 unknown_status NCT00581165
Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith Etanercept treatment 4 completed NCT02733874
A Trial That Compound Clobetasol Propionate Ointment Treats Patients With Mild to Moderate Psoriasis Vulgaris. treatment 4 completed NCT01147874
Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice No drug interventions diagnostic 4 completed NCT06376474
To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage No drug interventions treatment 1 recruiting NCT03597620
Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis No drug interventions treatment 4 completed NCT05957120
Subclinical Impairment of Cardiovascular System in Patients With Psoriasis No drug interventions Not Available Not Available completed NCT00001420
Study of Psoriatic Arthritis No drug interventions Not Available Not Available completed NCT03875482
A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT02107482
Use of Localized NB-UVB (Levia®) in the Treatment of Plaque-psoriasis No drug interventions treatment Not Available completed NCT02258282
Safety and Efficacy of Etanercept in Patients With Psoriasis treatment Not Available unknown_status NCT02474082
Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis. treatment 3 completed NCT05644782
Dietary Approach to Mild-to-moderate Psoriasis No drug interventions treatment Not Available recruiting NCT00604682
Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis treatment 2 completed NCT03255382
A Study to Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic Therapy treatment 3 completed NCT02397382
Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis treatment 1 completed NCT00150982
Alefacept Mechanism of Action in Psoriasis treatment 2 completed NCT00254982
Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED) treatment 3 completed NCT02970331
A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque Psoriasis treatment 2 withdrawn NCT05132231
Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity Not Available Not Available recruiting NCT06077331
A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis No drug interventions treatment 2 recruiting NCT00679731
A Study of Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT05458531
Monitoring of Inflammatory Conditions No drug interventions Not Available Not Available completed NCT01225731
A Study to Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003) treatment 2 completed NCT04347473
ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis. treatment 4 recruiting NCT01844973
Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients basic_science 1 completed NCT02097173
Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen Not Available 1 completed NCT06180473
Evaluation of Tolerability, Efficacy and Adherence to Treatment With Wynzora Cream No drug interventions Not Available Not Available not_yet_recruiting NCT03624127
Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis treatment 3 completed NCT01661127
Clinical Study of PET/CT and Association With Metabolic Syndrome/Depressive Symptoms in Psoriasis No drug interventions Not Available Not Available unknown_status NCT04785027
Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis No drug interventions treatment 1 / 2 recruiting NCT04603027
A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis treatment 2 completed NCT02432027
Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test treatment 1 / 2 completed NCT01744327
TL1A Expression in Psoriatic Skin No drug interventions Not Available Not Available unknown_status NCT03262727
The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients treatment 1 completed NCT03656627
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease treatment 1 terminated NCT05789576
A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region treatment 4 completed NCT00261976
A Long-term Safety Study of Infliximab (Remicade) Not Available Not Available completed NCT05283876
Excimer Light in Psoriasis No drug interventions treatment Not Available completed NCT05725876
Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis. other 1 not_yet_recruiting NCT01937260
Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects other 1 completed NCT03540160
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) treatment 3 terminated NCT03485560
Revitalization of Damaged Skin Due to Chronic Skin Diseases No drug interventions treatment 0 unknown_status NCT00005660
The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases No drug interventions Not Available Not Available completed NCT03535194
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) treatment 3 completed NCT04848194
Pleiotropic Role of TRPV1 in Psoriasis Inflammation No drug interventions basic_science Not Available completed NCT03542994
A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis No drug interventions treatment 1 completed NCT03050294
Evaluating Treatment Resistant Dermatitis TaroIIR treatment 4 completed NCT06075394
Hypertension, Antihypertensive Medication Use, and Risk of Psoriasis No drug interventions Not Available Not Available completed NCT02762994
International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis treatment 2 completed NCT04722094
Prevalence of Periodontitis in Patients With Plaque Psoriasis. A Cross-sectional Study No drug interventions Not Available Not Available unknown_status NCT00293891
A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis treatment 3 completed NCT02910791
The Role of Bacterial Toxins in Human Skin Disease No drug interventions Not Available Not Available unknown_status NCT04418791
Modified Intermittent Fasting in Psoriasis No drug interventions treatment Not Available completed NCT06216691
Smart Phone Delivered Cognitive Behavioral Therapy for Adults With Psoriasis and Co-Morbid Depression Symptoms No drug interventions other Not Available recruiting NCT00279162
Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis treatment 3 completed NCT04167462
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea treatment 3 completed NCT04587362
The Diagnostic Ultrasound Enthesitis Tool (DUET) Study No drug interventions Not Available Not Available completed NCT02550080
Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome treatment 4 unknown_status NCT00372580
Effect of Atopic Diathesis as Assessed by Serum Th1/Th2 Cytokine Profile on Clinical Manifestation of Psoriasis No drug interventions Not Available Not Available unknown_status NCT03478280
Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis treatment 4 unknown_status NCT01205880
Study to Evaluate Vectical in Combination With Clobex Spray to Treatment Plaque Psoriasis treatment 4 completed NCT01139580
The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis treatment 3 completed NCT03904680
Studying the Effect of Methotrexate Alone Versus Methotrexate and Vitamin D on the Cardiovascular Risk of Psoriatic Patients treatment 4 unknown_status NCT00998829
Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis No drug interventions Not Available Not Available completed NCT04745429
Non-pharmacological Mitigation of Psoriasis No drug interventions treatment Not Available completed NCT01916629
Photocil (Topical) for the Treatment of Psoriasis Vulgaris treatment Not Available completed NCT00763529
Elocon vs Fluticasone in Localized Psoriasis (P03197) treatment 4 completed NCT03339089
Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases No drug interventions Not Available Not Available completed NCT00098189
Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Chronic Plaque-Type Psoriasis No drug interventions Not Available Not Available completed NCT05728489
A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis No drug interventions treatment 1 recruiting NCT03726489
Light Treatment Effectiveness (LITE) Study No drug interventions other Not Available completed NCT03724292
An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers No drug interventions treatment 1 completed NCT00930592
Peds Metabolic Syndrome in Psoriasis No drug interventions Not Available Not Available completed NCT01866592
Vascular Inflammation in Psoriasis - Extension Study treatment 4 completed NCT05971992
INulin-type Fructans-induced Gut Microbiota Modulation Impact on GUT-SKIN Axis Parameters in Psoriasis No drug interventions basic_science Not Available enrolling_by_invitation NCT06005792
Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis No drug interventions treatment 1 active_not_recruiting NCT01706692
Swiss Dermatology Network of Targeted Therapies (SDNTT) Not Available Not Available recruiting NCT02922192
Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis No drug interventions Not Available Not Available completed NCT02417792
The Association Between Psoriasis and Intestinal Bacterial Population No drug interventions Not Available Not Available completed NCT03069144
Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis treatment 1 / 2 completed NCT03058744
Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis treatment 1 completed NCT05010044
MBCT for Psoriasis Patients With Anxiety and Depression No drug interventions treatment Not Available unknown_status NCT00747344
A Phase 3 Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis treatment 3 completed NCT05506644
Biofeedback for Psoriasis No drug interventions supportive_care Not Available completed NCT00716144
Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque Psoriasis treatment 2 completed NCT01360944
Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test No drug interventions treatment 2 completed NCT00879944
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index No drug interventions Not Available Not Available completed NCT04170244
Study of Skin Microbiome in AD and PS Patients No drug interventions Not Available Not Available recruiting NCT01254240
Efficacy Study of Two Choices of Phototherapy on Itching Skin Diseases No drug interventions treatment 2 completed NCT04722640
Exploring the Effects of IL-23 Inhibition by Risankizumab on Psoriasis Autoimmunity treatment 4 unknown_status NCT05908240
Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis No drug interventions other Not Available recruiting NCT03254667
LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis Not Available Not Available enrolling_by_invitation NCT04571567
A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis treatment 4 completed NCT02173301
A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis treatment 2 completed NCT02387801
A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe Psoriasis treatment 3 completed NCT02196701
Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study treatment 3 completed NCT02413801
Serum, Cellular and Imaging Markers of Arthritis in Psoriasis Patients No drug interventions Not Available Not Available active_not_recruiting NCT02347501
Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP) treatment 2 completed NCT01154101
Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis treatment 2 completed NCT01488201
A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis treatment 1 completed NCT00462072
Centocor Microarray Study of Patients treatment 4 completed NCT00714272
Granulocytapheresis in Psoriasis No drug interventions treatment Not Available terminated NCT00692172
Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis treatment 3 completed NCT00527072
PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept treatment 3 completed NCT03895372
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis treatment 2 completed NCT06458868
An Open-label Controlled Trial: Effectiveness of Balneotherapy in Palmoplantar Psoriasis and Contact Dermatitis. No drug interventions treatment Not Available completed NCT01563068
Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis other 1 completed NCT02896868
A Study of LY3041658 in Participants With Skin Diseases basic_science 1 completed NCT03392168
Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis No drug interventions treatment 1 / 2 completed NCT05056168
Validation of a Dermatology-Specific Treatment Satisfaction Instrument No drug interventions Not Available Not Available active_not_recruiting NCT02447068
Luma Light System Proof of Concept Study in Subjects With Mild to Moderate Psoriasis No drug interventions treatment Not Available unknown_status NCT03964168
An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers No drug interventions Not Available Not Available completed NCT03004768
Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants treatment 1 completed NCT01460069
The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis treatment Not Available completed NCT00760669
An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants Not Available Not Available completed NCT00638469
UVB-311nm After Initial Slow Response to Adalimumab in Psoriasis No drug interventions treatment Not Available unknown_status NCT05621369
Psorcast Mobile Study No drug interventions Not Available Not Available recruiting NCT03004846
A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis treatment 1 / 2 completed NCT05076812
Interleukin 38 as a Biomarker for Metabolic Syndrome in Psoriatic Patients No drug interventions Not Available Not Available unknown_status NCT03223012
Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service No drug interventions Not Available Not Available completed NCT01403012
BOSTRIP: Biomarkers of Systemic Treatment Response in Psoriasis No drug interventions Not Available Not Available terminated NCT06361212
Ethoximod Pharmacokinetics In Healthy Subjects No drug interventions treatment 1 completed NCT01474512
A Phase 3 Study in Participants With Moderate to Severe Psoriasis treatment 3 completed NCT01722812
Cromoglicate in Psoriasis treatment 2 completed NCT06049810
IBI112 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment No drug interventions treatment 3 active_not_recruiting NCT01018810
A Study for Adults With Plaque Psoriasis No drug interventions treatment 2 terminated NCT03419910
An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants treatment 1 completed NCT00116181
Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis treatment 3 completed NCT00110981
Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis treatment 4 completed NCT02294981
Excimer Laser Phototherapy Outcomes in the Treatment of Psoriasis No drug interventions treatment Not Available terminated NCT00005781
Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles No drug interventions Not Available Not Available completed NCT01628081
The Effect of Alga Dunaliella Bardawil on Psoriasis No drug interventions treatment 3 unknown_status NCT06319781
A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo No drug interventions Not Available Not Available recruiting NCT02954081
APremilast After FumaRic Acid Ester Treatment Not Available Not Available completed NCT00689481
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies No drug interventions treatment 3 completed NCT03448081
Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene treatment 2 completed NCT01908595
Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis treatment 3 completed NCT01045395
Efficacy of Two Algae Formulations on Lipid Metabolism, Inflammation and Oxidative Stress Status in Individuals With Psoriasis No drug interventions basic_science 1 completed NCT06583395
Quest to Analyze One Thousand Humans Meditating No drug interventions Not Available Not Available enrolling_by_invitation NCT02849795
Evaluation of Adipokines and Fat Tissue in Psoriasis and Psoriatic Arthritis No drug interventions basic_science Not Available completed NCT04274595
Role of Reverse Transcriptase Inhibitors in the Treatment of Psoriasis treatment Not Available completed NCT04191395
Evolution and Treatments of Chronic Inflammatory Systemic Diseases No drug interventions Not Available Not Available recruiting NCT01122095
Cross-sectional Evaluation of Biological Markers of Cardiovascular Disease in Children and Adolescents With Psoriasis No drug interventions Not Available Not Available unknown_status NCT05701995
A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting treatment 4 active_not_recruiting NCT03767114
Estimation of Level of ERAP1 Expression in Lesional and Non Lesional Skin of Psoraitic Patients and Healthy Controls. No drug interventions diagnostic Not Available completed NCT00645814
Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis treatment 2 completed NCT04417114
SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE prevention 4 withdrawn NCT03475914
Characterization of Cutaneous Microbiota in the Psoriasis Pathogenesis No drug interventions Not Available Not Available completed NCT02796014
Assessment of Dermatologic Family Impact Scale in the Parents of Children With Psoriasis No drug interventions Not Available Not Available completed NCT03358914
The PsoTeenQOL - Preliminary Reliability and Validity No drug interventions Not Available Not Available completed NCT05866614
A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps Not Available Not Available recruiting NCT03125655
Regulation of Inflammatory Genes in Psoriasis No drug interventions Not Available Not Available recruiting NCT03511755
12-Week Study Assessing Change in Psoriasis Severity and Level of Stress Using TEN No drug interventions treatment Not Available completed NCT00763555
Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis treatment 2 completed NCT02762955
Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT04629950
Rimegepant in Moderate Plaque-type Psoriasis treatment 2 active_not_recruiting NCT00585650
Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet treatment 1 / 2 completed NCT03960450
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Topical Administration of BOS-475 in Healthy Subjects and Patients With Psoriasis No drug interventions treatment 1 completed NCT00606450
Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis treatment 2 completed NCT02694523
BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis treatment 3 completed NCT00602823
Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva) No drug interventions Not Available Not Available completed NCT00669123
Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis treatment 4 completed NCT00808223
Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe Psoriasis treatment 2 completed NCT02918123
Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis No drug interventions treatment 1 unknown_status NCT01265823
Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis treatment 4 completed NCT00151008
Bexarotene With Narrow-Band UVB for Psoriasis No drug interventions treatment 2 completed NCT05406908
Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseases prevention 4 completed NCT01001208
The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis treatment 3 completed NCT06125808
Efficacy and Safety Study of HRO350 in Patients With Mild-to-moderate Psoriasis (the 'HeROPA' Study). No drug interventions treatment 2 active_not_recruiting NCT03832738
Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis No drug interventions treatment 2 completed NCT04465838
Chinese Psoriasis Real World Evidence Research No drug interventions Not Available Not Available recruiting NCT02931838
Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis treatment 2 completed NCT01425138
Systematic Review And Meta-Analysis Of Psoriasis Treatments. No drug interventions Not Available Not Available completed NCT01404338
Assessment for Tachyphylaxis to Topical Corticosteroids in the Treatment of Psoriasis basic_science 1 completed NCT05051943
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response No drug interventions Not Available Not Available completed NCT01964443
Clinical Assessment and Psychosocial Impact of Psoriasis No drug interventions Not Available Not Available completed NCT03097003
A Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in Belgium Not Available Not Available completed NCT00329303
Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis treatment 2 completed NCT01988103
Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis treatment 2 completed NCT04799990
Study to Assess Adverse Events When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Real World Setting Not Available Not Available withdrawn NCT05442190
Topical SGX302 for Mild-to-Moderate Psoriasis treatment 2 recruiting NCT01708590
Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects treatment 3 terminated NCT04200690
Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory Diseases No drug interventions health_services_research Not Available active_not_recruiting NCT05547490
A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis No drug interventions Not Available Not Available completed NCT02978690
Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis treatment 1 completed NCT00655564
Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis treatment 4 completed NCT03979664
Iontophoresis in Psoriasis treatment 0 withdrawn NCT04239521
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata No drug interventions Not Available Not Available completed NCT04119102
Duobrii in Combination With Biologics treatment 4 recruiting NCT02940002
BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test other 1 completed NCT03556202
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) treatment 3 terminated NCT00301002
Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis treatment 2 completed NCT05428202
Phase I Study of GN-037 Cream for Psoriasis No drug interventions treatment 1 completed NCT00769184
Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis treatment Not Available completed NCT00454584
An Efficacy and Safety Study of CNTO 1275 Compared to Etanercept in Patients With Plaque Psoriasis treatment 3 completed NCT03254784
A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation treatment 1 completed NCT00358384
Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034 treatment 1 completed NCT03629379
Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions basic_science 4 completed NCT00407979
Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis No drug interventions Not Available Not Available completed NCT05125679
Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis treatment 4 terminated NCT05295979
Chinese Medicine for Patients With Psoriasis No drug interventions treatment 2 recruiting NCT00735787
Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet treatment 4 completed NCT00237887
Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis treatment 3 completed NCT03478787
Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT01206387
Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis treatment 3 completed NCT04149587
A Study of Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent Regimen Not Available Not Available completed NCT00408187
Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients treatment 3 completed NCT05270733
Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics treatment 4 recruiting NCT02776033
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis No drug interventions treatment 2 completed NCT06408454
Interleukin- 17 (IL-17), Bcl-3, and NF-kappa-B Inhibitor Zeta (IκBζ) Expression Levels in the Psoriasis Patients No drug interventions Not Available Not Available completed NCT02644954
Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis treatment 3 unknown_status NCT05203354
Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin treatment 4 completed NCT00368654
Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy treatment 1 / 2 completed NCT01812954
Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis Not Available Not Available completed NCT02203851
Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis treatment 2 completed NCT03451851
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants treatment 3 active_not_recruiting NCT00833053
Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315) treatment 3 terminated NCT05514353
A Phase 1 Study to Assess Single and Multiple Ascending Doses of PBI-100 Topical Cream No drug interventions treatment 1 completed NCT03733353
A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis treatment 1 completed NCT06380153
To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment No drug interventions treatment 1 recruiting NCT01163253
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis treatment 3 terminated NCT03594877
Effect of Sublimated Mare Milk Supplement on Gut Microbiome in Psoriasis Patients No drug interventions treatment Not Available completed NCT01045577
A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque Psoriasis treatment 2 completed NCT01646177
A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3) treatment 3 completed NCT03051347
Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments No drug interventions other Not Available completed NCT04560647
Pilot Studies Testing Levels of P63 in Psoriasis Skin Lesions No drug interventions Not Available Not Available completed NCT03518047
Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian Federation treatment 3 completed NCT03168347
Assessing Patient Confidence in Biologic Medications No drug interventions health_services_research Not Available active_not_recruiting NCT06242847
Role of Insulin Action in Psoriasis Pathogenesis No drug interventions Not Available Not Available recruiting NCT01597245
A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2) treatment 3 completed NCT02581345
Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis treatment 3 completed NCT03816345
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer treatment 1 recruiting NCT01283698
Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis No drug interventions treatment 2 completed NCT00727298
Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) Not Available Not Available completed NCT01088698
Golimumab Plus UVB-311nm in Psoriasis No drug interventions treatment Not Available terminated NCT00749398
Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047) Not Available Not Available completed NCT02326298
An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) treatment 3 completed NCT05200598
Cardiovascular Risk Predictors in Patients With Psoriasis No drug interventions Not Available Not Available recruiting NCT01029405
Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis treatment 2 completed NCT03179605
Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06 treatment 2 terminated NCT04414605
Oral Chinese Herbal Medicine Concurrent With Secukinumab for Severe Plaque Psoriasis treatment 0 unknown_status NCT03526705
The Effect of NB-UVB on Interleukin-36 Levels in Psoriasis No drug interventions other Not Available unknown_status NCT03421197
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) treatment 2 completed NCT03850483
Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis treatment 2 completed NCT01246583
CP-690-550 Ointment For Chronic Plaque Psoriasis treatment 2 completed NCT01233583
Regulatory T-cells in Psoriasis Patients as Targets for Therapy Not Available Not Available completed NCT03099083
Real-World Outcome of Psoriasis Subjects in Korea on Adalimumab No drug interventions Not Available Not Available completed NCT03998683
A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis treatment 3 completed NCT01878461
Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis treatment 3 completed NCT02940561
BE Study in Patients - Methotrexate Tablets Not Available 1 unknown_status NCT03955861
Ultrasound Enthesitis Response in Psoriatic Arthritis Not Available Not Available completed NCT03888261
Mind-Body Approaches for Medical Conditions No drug interventions supportive_care Not Available unknown_status NCT01077128
Greek Study of the Quality of Life in Patients With Psoriasis Treated With Adalimumab No drug interventions Not Available Not Available completed NCT04359628
How Does Patients' Overall Assessment of Their Health Vary Across and Within Different Disease Groups? No drug interventions Not Available Not Available unknown_status NCT02933528
Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS No drug interventions treatment 2 completed NCT05858528
HIPPOCRATES Prospective Observational Study No drug interventions Not Available Not Available recruiting NCT03840928
PatientSpot Formerly Known as ArthritisPower No drug interventions Not Available Not Available recruiting NCT00234728
Study of a New Dressing for Use With Topical Medications No drug interventions treatment Not Available completed NCT01235728
A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022) treatment 1 completed NCT05523011
Safety and Tolerability Study of MSC Exosome Ointment No drug interventions treatment 1 completed NCT00333411
Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis No drug interventions treatment 2 completed NCT04746911
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216) treatment 2 completed NCT00111111
An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis treatment 3 completed NCT03392311
Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis treatment 1 / 2 completed NCT05225493
HIV Indicator Diseases in Hospital and Primary Care No drug interventions Not Available Not Available unknown_status NCT01043393
Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study treatment 2 completed NCT03358693
Molecular Signatures in Inflammatory Skin Disease Not Available Not Available recruiting NCT02955693
Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008 treatment 1 completed NCT00823693
Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis treatment 2 completed NCT02626793
A Study of Otezla® in Patients With Plaque Psoriasis Under Routine Conditions No drug interventions Not Available Not Available completed NCT01094093
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis No drug interventions treatment 1 completed NCT00007293
Scalp Psoriasis Treatment With a Fiber Optic Comb No drug interventions treatment 1 / 2 completed NCT02205593
Haut-Tief Patient Education on Psoriasis and Eczema No drug interventions supportive_care Not Available unknown_status NCT02993471
A Study of Ixekizumab in Participants With Plaque Psoriasis basic_science 1 completed NCT04809571
Non-invasive Photoacoustic Imaging of Skin Inflammatory Disorders With Machine Learning-assisted Scoring No drug interventions diagnostic Not Available unknown_status NCT03279978
This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357 treatment 1 completed NCT02122978
Comparing Mindfulness Based Cognitive Therapy and Mindfulness Based Self-compassion Therapy in a Psoriasis Sample No drug interventions Not Available Not Available unknown_status NCT02576678
A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis treatment 2 completed NCT05970978
A Study of IBI112 in Chinese Patients With Psoriasis Who Were Previously Treated With Biologics No drug interventions treatment 2 active_not_recruiting NCT06574178
Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet No drug interventions other Not Available recruiting NCT03201978
A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects treatment 1 withdrawn NCT05391178
Improving Disease Severity No drug interventions health_services_research Not Available active_not_recruiting NCT00941278
An Efficacy and Safety Study of PH-10 Aqueous Hydrogel for the Treatment of Plaque Psoriasis treatment 2 completed NCT03218488
A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis Not Available Not Available recruiting NCT06213688
Involvement of Pollutants in Atopic Dermatitis and Psoriasis No drug interventions basic_science Not Available not_yet_recruiting NCT01079988
Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence treatment 4 completed NCT01137188
Effect of Weight Loss on Psoriasis No drug interventions prevention Not Available completed NCT00195507
Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis treatment 4 completed NCT03922607
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Participants With Chronic Plaque Psoriasis treatment 1 completed NCT00217009
Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases. No drug interventions treatment 0 terminated NCT03240809
An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects treatment 4 recruiting NCT05307809
Cytokine Expression in Psoriasis Patients with and Without Joint Involvement No drug interventions basic_science Not Available recruiting NCT03706209
Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis No drug interventions treatment 2 completed NCT03018509
Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects No drug interventions treatment 1 completed NCT00293709
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists Not Available Not Available completed NCT01228409
Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects? treatment 4 unknown_status NCT06102356
Impact of Clinical and Psychological Factors on Treatment Satisfaction in Psoriatic Patients in Biological Therapy No drug interventions Not Available Not Available recruiting NCT03074656
The Norwegian Drug Monitoring Study No drug interventions treatment Not Available completed NCT03662685
Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris basic_science 4 active_not_recruiting NCT00870285
Ustekinumab Plus UVB-311nm in Psoriasis No drug interventions treatment Not Available completed NCT04488185
An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound treatment 4 withdrawn NCT03329885
A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis treatment 1 / 2 terminated NCT03942185
Chinese Herbal Medicine for Psoriasis Vulgaris: a Real World Study treatment 2 unknown_status NCT04316585
A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants No drug interventions treatment 1 completed NCT01229085
Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With Psoriasis treatment 3 completed NCT04818385
Study to Assess the Change in Disease State When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Taiwan No drug interventions Not Available Not Available recruiting NCT03361215
Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis No drug interventions Not Available Not Available recruiting NCT01387815
Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis Not Available Not Available completed NCT01170715
Psoriasis Inflammation and Systemic Co Morbidities basic_science Not Available completed NCT02599415
Anti-psoriatic Effect of TL01 Light Therapy No drug interventions diagnostic Not Available completed NCT03219437
A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT00723437
Evaluation of the Efficacy of Acitretin Therapy for Nail Psoriasis Not Available 4 completed NCT04410237
Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque Psoriasis With a Novel Needle-free Drug-delivery System No drug interventions other 0 completed NCT03392337
An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients No drug interventions treatment Not Available recruiting NCT00307437
A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis treatment 3 completed NCT06477237
Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis No drug interventions treatment 3 recruiting NCT02786732
Study to Evaluate Broadlumab vs Placebo and Ustekinumab treatment 3 terminated NCT04277832
Evaluating of New Screening Tool for Arthritis* in Psoriasis No drug interventions Not Available Not Available completed NCT04765332
Evaluation of the Sensitivity and Specificity of a Novel Quality of Life Tool to Assess the Treatment Satisfaction in Psoriasis Patients No drug interventions Not Available Not Available completed NCT02203032
A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab treatment 3 completed NCT04515732
Danish Population-based Assessment of Psoriasis and Psoriatic Arthritis (DANPAPP) diagnostic 4 unknown_status NCT01490632
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis treatment 2 completed NCT01137032
Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population treatment 4 completed NCT06399432
Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors No drug interventions treatment Not Available recruiting NCT01149252
Determination of the Efficacy and Safety of Psoralait Versus Placebo in the Treatment of Psoriasis No drug interventions treatment 4 terminated NCT00109252
A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g treatment 3 completed NCT00167752
Psychiatric Problems in Chronic Skin Diseases No drug interventions Not Available Not Available completed NCT04058652
Use of Transcutaneous Electrical Nerve Stimulation for Reducing Biologic Injection Site Pain(TENS Study) No drug interventions other Not Available active_not_recruiting NCT01300052
AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis treatment 2 completed NCT00663052
Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis treatment 4 completed NCT05448352
Asking People With Psoriasis About Lifestyle and Eating No drug interventions Not Available Not Available completed NCT01162252
Improving Psoriasis Through Health and Well-Being No drug interventions treatment Not Available completed NCT00192452
Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque Psoriasis treatment 2 completed NCT00867100
Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827 No drug interventions treatment 1 completed NCT02572700
Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis No drug interventions Not Available Not Available recruiting NCT02850900
Oral Psoriasis Treatment Adherence and Intervention Study No drug interventions treatment Not Available completed NCT03090100
A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis treatment 3 completed NCT02775500
Apremilast Pregnancy Exposure Registry Not Available Not Available active_not_recruiting NCT02750800
Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) Not Available Not Available completed NCT02457000
Sleep, Circadian Rhythm & Skin Health No drug interventions Not Available Not Available completed NCT05326659
Efficacy and Safety of Benvitimod Cream in the Retreatment of Mild to Moderate Psoriasis treatment Not Available unknown_status NCT05894759
The Impact of Different Relaxation Techniques on Psoriasis Patients With an Elevated Psychological Stress Level No drug interventions treatment Not Available recruiting NCT05320159
Treatment Effectiveness Among Psoriasis Patients Treated With Cosentyx (Secukinumab) Not Available Not Available completed NCT02785159
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis treatment 2 completed NCT02408159
Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy prevention 4 terminated NCT03210259
The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis treatment 3 completed NCT00895375
Prevalence of Sleep Disturbances in Psoriasis No drug interventions Not Available Not Available completed NCT03774875
A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of Life treatment 4 completed NCT00715975
Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis treatment 2 / 3 completed NCT05427175
Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis treatment 4 unknown_status NCT04908475
Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy treatment 4 completed NCT01155570
Special Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis (All Patients Investigation) No drug interventions Not Available Not Available completed NCT02595970
Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis treatment 3 completed NCT00578370
Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test treatment 1 / 2 completed NCT02649270
Tolerability, Safety and Pharmacokinetic Study of Humanized Anti-CD6 Monoclonal Antibody Injection in Chinese Psoriasis No drug interventions treatment 1 terminated NCT04549870
Efficacy of Roflumilast in the Treatment of Psoriasis treatment 2 completed NCT02684370
BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis treatment 3 completed NCT03236870
A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China No drug interventions Not Available Not Available completed NCT05706870
Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque Psoriasis treatment 2 completed NCT03131570
Safety and Efficacy of Secukinumab in Mild Psoriasis treatment 2 completed NCT01181570
Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea treatment 4 completed NCT00482170
Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept No drug interventions treatment 3 completed NCT00504270
A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis. No drug interventions treatment 2 completed NCT03873142
The Effectiveness of a Mindful Parenting Intervention for Parents of Children With Psoriasis and Parents of Children With Eczema No drug interventions treatment Not Available completed NCT02564042
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis treatment 2 completed NCT02690142
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035 treatment 1 completed NCT06033742
A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10374 in Healthy Subjects No drug interventions treatment 1 completed NCT00407342
Alefacept (Amevive) With or Without Narrowband UVB Treatment in Patients With Psoriasis. treatment Not Available completed NCT04930042
Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis treatment 3 completed NCT01522742
Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study No drug interventions Not Available Not Available terminated NCT05184699
The Effect of Dietary Intervention on Endothelial Glycocalyx in Psoriasis No drug interventions prevention Not Available recruiting NCT01483599
A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type Psoriasis treatment 2 completed NCT05451199
A Clinical Study of ICP-488 in Healthy Subjects and Patients With Psoriasis No drug interventions treatment 1 recruiting NCT01690299
Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis treatment 3 completed NCT03635099
This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is No drug interventions treatment 2 completed NCT03718299
A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis treatment 4 completed NCT03848806
Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis treatment 2 completed NCT05401006
Effect of Acitretin Versus Narrowband Ultraviolet B on Neopterin Level in Psoriatic Patients . treatment 4 unknown_status NCT04275206
The Anti-inflammatory Effects of Harkány Medicinal Water No drug interventions treatment Not Available unknown_status NCT00143806
Transitioning From Cyclosporine to Alefacept in Psoriasis treatment 2 completed NCT02195349
A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque Psoriasis No drug interventions treatment 1 completed NCT04848649
Shortening Treatments Of Chronic Inflammatory Conditions No drug interventions basic_science Not Available unknown_status NCT03440736
Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome treatment 4 completed NCT03469336
Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis treatment 1 completed NCT04693936
Metabolic Biomarkers in Hashimoto's Thyroiditis and Psoriasis No drug interventions diagnostic Not Available active_not_recruiting NCT03798236
Study to Assess the Safety and Tolerability of PBF-1650 in Healthy Volunteers. No drug interventions treatment 1 completed NCT04826536
A Study of Treatment Patterns and Clinical Outcomes of Psoriasis in Japan No drug interventions Not Available Not Available completed NCT03073213
A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris basic_science 1 completed NCT03265613
Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis No drug interventions treatment 1 / 2 completed NCT01539213
Distribution of Secukinumab (AIN457) Into Dermal Interstitial Fluid After a Single Subcutaneous Administration of 300 mg basic_science 1 completed NCT00932113
Mechanism of Action Study for Psoriasis basic_science 4 completed NCT03445013
A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis No drug interventions treatment 1 completed NCT04175613
A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis treatment 3 active_not_recruiting NCT06073613
Periodontal Status in Patients With Chronic Skin Diseases No drug interventions Not Available Not Available completed NCT04655313
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215) treatment 2 completed NCT05110313
Effects of Tildrakizumab on Epigenetic Age basic_science 4 completed NCT02592018
Immunologic Response to Secukinumab in Plaque Psoriasis basic_science 4 completed NCT04950218
The Psoriasis Echo Study No drug interventions Not Available Not Available recruiting NCT02740218
A Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice No drug interventions Not Available Not Available completed NCT06126718
Phase I Randomized, Open-label, Parallel-controlled, Pharmacokinetic and Safety Study of BR201 Injection Versus Cosentyx in Healthy Male Subjects treatment 1 not_yet_recruiting NCT01139918
Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic Arthritis No drug interventions Not Available Not Available completed NCT00437619
A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis. treatment 4 completed NCT03539419
Study to Evaluate the Benefits for the Patient Associated With the Treatment of Plaque Psoriasis With Apremilast After Other Systemic Treatment in Conditions of Clinical Practice in Spain No drug interventions Not Available Not Available completed NCT02325219
An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis treatment 3 completed NCT04168619
MTX-related Liver Toxicity in Psoriasis Patients, Using Ultrasound-based Techniques as a Diagnostic Tool Not Available Not Available unknown_status NCT04117919
Psoriasis、Indigo Naturalis、Chinese Medicine Medicated Bath treatment 2 unknown_status NCT01126619
A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe Psoriasis No drug interventions Not Available Not Available completed NCT01761019
A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy treatment 4 completed NCT02407041
An Open-Label, Phase 2a Study to Evaluate Safety and Efficacy of GR-MD-02 for Treatment of Psoriasis treatment 2 completed NCT02707341
The Corrona Psoriasis (PSO) Registry No drug interventions Not Available Not Available enrolling_by_invitation NCT02668341
Cross Sectional Analysis of Healthcare for Psoriasis in 4 European Countries No drug interventions Not Available Not Available unknown_status NCT03925441
Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea No drug interventions Not Available Not Available completed NCT04102241
Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis No drug interventions treatment 2 completed NCT05084417
A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological Conditions No drug interventions Not Available Not Available enrolling_by_invitation NCT03406117
A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests No drug interventions basic_science 4 completed NCT00192517
Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis treatment 2 completed NCT01903317
Evaluation of Vitamin D Levels in Psoriasis Patients No drug interventions Not Available Not Available withdrawn NCT05504317
A Study of AK111 in Subjects With Moderate-to-severe Plaque Psoriasis No drug interventions treatment 1 completed NCT02472717
Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study treatment 2 withdrawn NCT00293917
A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis treatment 3 completed NCT00106834
A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis treatment 3 completed NCT02917434
Effects of Weight-loss Treatment in Obese Patients With Psoriatic Arthritis No drug interventions treatment Not Available completed NCT01422434
LEO 90105 Ointment in Japanese Subjects With Psoriasis treatment 3 completed NCT01262534
A Study to Assess the Clinical Profile of Patients in Spain With Moderate to Severe Psoriasis. No drug interventions Not Available Not Available completed NCT00773734
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study) treatment 2 completed NCT02483234
Psoriasis-Arthritis & Bone Program treatment 2 completed NCT00111124
Enbrel® in Psoriatic Arthritis treatment 4 completed NCT01316224
Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment No drug interventions Not Available Not Available completed NCT01782924
A Phase 3 Clinical Study of KHK4827 treatment 3 completed NCT01763424
Nicotinamide in the Treatment of Psoriasis treatment 2 / 3 completed NCT04275024
Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients treatment Not Available completed NCT02131324
DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis treatment 2 completed NCT01797224
OTIS Autoimmune Diseases in Pregnancy Project No drug interventions Not Available Not Available recruiting NCT02552316
Psoriasis Microbiome and Phototherapy No drug interventions other Not Available completed NCT05522816
KX01 Ointment Phase 1 Study in Patients With Plaque Type Psoriasis treatment 1 completed NCT00373516
Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment of Plaque-Type Psoriasis treatment 2 completed NCT00437216
Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis Not Available Not Available completed NCT04308616
Utility of Squamous Cell Carcinoma Antigen (SCCA) in Psoriasis No drug interventions Not Available Not Available completed NCT03791216
Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment No drug interventions Not Available Not Available active_not_recruiting NCT02101216
Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers other 1 completed NCT04633616
Tailored Patient-Provider Communication (TPPC): Evaluating the Impact of TPPC in Dermatology Patients No drug interventions other Not Available completed NCT05571696
Mind Matters: a High Touch, Low Cost Approach to Improving Mental Health Outcomes in Patients with Psoriatic Diseases No drug interventions other Not Available recruiting NCT00292396
Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis treatment 2 completed NCT04751396
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors No drug interventions Not Available Not Available recruiting NCT01610596
A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis treatment 2 completed NCT04146558
Ayurvedic Treatment Package in Plaque Psoriasis No drug interventions treatment 3 unknown_status NCT06584058
HPP737 Substance Balance Study in Human No drug interventions other Not Available not_yet_recruiting NCT05125458
Relationships Among Inflammation, Physical and Mental Health in Subjects With Chronic Inflammatory Physical Diseases. No drug interventions Not Available Not Available completed NCT06032858
Efficacy and Safety of Apremilast in Psoriasis treatment 4 completed NCT01132235
An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use treatment 4 unknown_status NCT02358135
Collaborative Connected Health (CCH) for PCORI No drug interventions supportive_care Not Available completed NCT06277635
Effect of Silymarin Against Methotrexate-induced Liver Injury in Rheumatic Diseases treatment Not Available recruiting NCT04271735
Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis No drug interventions basic_science Not Available completed NCT04837235
Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects No drug interventions treatment 1 completed NCT03818035
A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis treatment 3 active_not_recruiting NCT02274363
A Study to Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type Psoriasis No drug interventions Not Available Not Available completed NCT03701763
Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis treatment 3 terminated NCT03738163
A Clinical Investigation With Epaderm® Cream No drug interventions treatment Not Available completed NCT03987763
A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis No drug interventions treatment 4 recruiting NCT02322086
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 treatment 2 completed NCT02786186
A Registry of Patients With Moderate to Severe Plaque Psoriasis Not Available Not Available active_not_recruiting NCT05636839
UVB-induced Treg Cells Exert Antigen-specific Suppression Through LAG-3 No drug interventions basic_science Not Available recruiting NCT05122039
ProspectIve Cohort psoriASiS fOllow-up (PICASSO) No drug interventions Not Available Not Available recruiting NCT04808739
Adalimumab Biosimilar in Clinical Practice Not Available Not Available completed NCT02451839
An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY) No drug interventions Not Available Not Available completed NCT04173039
Anti-Carbamylated Protein Antibodies in Psoriatic Arthritis No drug interventions diagnostic Not Available completed NCT00322439
Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis Not Available Not Available completed NCT03976622
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata Not Available Not Available unknown_status NCT02714322
MYL-1401A Efficacy and Safety Comparability Study to Humira® treatment 3 completed NCT00005922
Conditioning, the Placebo Effect, and Psoriasis treatment Not Available completed NCT00365625
Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris No drug interventions Not Available Not Available unknown_status NCT05118425
Dietary Perceptions and Practices in Chinese Psoriasis Patients No drug interventions Not Available Not Available completed NCT01439425
Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis No drug interventions treatment 4 unknown_status NCT01081730
Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database Not Available Not Available completed NCT00293930
A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis treatment 3 completed NCT02944630
Psychotherapy for Patients With Psoriasis: Effects in Quality of Life No drug interventions treatment Not Available unknown_status NCT01384630
Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis treatment 2 completed NCT04435730
Use of Serum M2BP and MSUS to Predict Arthritis in Psoriatic Patients No drug interventions Not Available Not Available completed NCT00050648
To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris treatment 1 / 2 completed NCT05064748
Phase IV Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in Adults treatment 4 recruiting NCT03135548
Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients treatment 2 completed NCT03145948
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis No drug interventions other 1 terminated NCT01107457
A Study in Participants With Moderate to Severe Psoriasis treatment 2 completed NCT05725057
Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis No drug interventions treatment 1 / 2 active_not_recruiting NCT04119557
A Study of LY3471851 in Participants With Psoriasis basic_science 1 completed NCT06172426
Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK Registry No drug interventions Not Available Not Available completed NCT00312026
A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet treatment 4 completed NCT03399526
1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat treatment 1 completed NCT00893126
Premature Coronary Artery Disease (CAD) in Severe Psoriasis No drug interventions Not Available Not Available completed NCT03577626
A Food Effect Study to Assess Pharmacokinetics of Hemay005 in Healthy Volunteers No drug interventions treatment 1 unknown_status NCT00643526
A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector No drug interventions treatment 0 completed NCT03455166
Identification of New Prognostic Markers in Psoriatic Arthritis No drug interventions other Not Available completed NCT01328366
Quality of Life and Psychosocial Factors Associated With Severe Psoriasis Following Treatment With Adalimumab No drug interventions Not Available Not Available completed NCT03253666
Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component) No drug interventions Not Available Not Available completed NCT04717466
Brain Changes in Psoriasis After Secukinumab Treatment basic_science 4 active_not_recruiting NCT01831466
Tofacitinib Ointment For Chronic Plaque Psoriasis treatment 2 completed NCT00791765
Moderate to Severe Plaque Psoriasis With Scalp Involvement treatment 4 completed NCT00205465
Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765 treatment 2 completed NCT03431974
Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis treatment 2 completed NCT04344574
Serum Level of IL31,33 and 36 in Egyptian Paients With Psoriasis No drug interventions Not Available Not Available unknown_status NCT00925574
A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With Psoriasis No drug interventions treatment 1 completed NCT01837420
A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Psoriasis treatment 2 completed NCT00748020
Narrow-Band UVB-Therapy in Psoriasis No drug interventions treatment 4 completed NCT00235820
Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis treatment 3 completed NCT00417820
Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis. No drug interventions treatment 1 completed NCT02191020
Efficacy and Safety Study of Total Glucosides of Paeony Combined With Acitretin to Treat Psoriasis treatment Not Available completed NCT01687582
Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients treatment Not Available completed NCT00800982
Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis treatment Not Available completed NCT04152382
A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis basic_science 1 terminated NCT05734482
Pharmacokinetic, Safety and Immunogenicity Study of CMAB015 and Cosentyx in Healthy Volunteers treatment 1 completed NCT05642182
Study of SFA002 in Patients With Mild to Moderate Psoriasis Plaques treatment 1 recruiting NCT01077882
Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic Dermatitis No drug interventions supportive_care 4 completed NCT01900782
Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo. No drug interventions treatment 3 withdrawn NCT04843631
Bioequivalence Phase I Study of BFI-751 Compared With EU and US-STELARA® in Healthy Adults treatment 1 completed NCT02207231
A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis treatment 3 completed NCT05003531
A Study to Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis No drug interventions treatment 2 completed NCT02905331
Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis treatment 3 completed NCT01894373
Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis No drug interventions treatment 1 / 2 completed NCT02366273
Diabetes and Psoriasis No drug interventions Not Available Not Available completed NCT01059773
A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate treatment 4 completed NCT00336973
A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent treatment 4 completed NCT05863273
Real World Study on the Efficacy and Safety of Apremilast in Chinese Patients With Moderate to Severe Plaque Psoriasis, a Multi Center, Prospective, Observational Trial（REACT） Not Available Not Available not_yet_recruiting NCT02995473
Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis No drug interventions treatment 2 completed NCT03924427
An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis treatment 3 completed NCT04305327
Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis treatment 3 terminated NCT00937027
Aminopterin Pharmacokinetic Study In Moderate to Severe Psoriasis treatment 1 completed NCT05004727
Multi-Center PAMPA Study treatment 4 recruiting NCT04870827
Effect of Chronic Inflammation on Myocardial Perfusion and Function No drug interventions Not Available Not Available terminated NCT04761627
A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT03374527
Recirculating Memory T Cells in the Pathogenesis of Psoriatic Arthritis and Cutaneous Psoriasis No drug interventions Not Available Not Available completed NCT01090427
A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS) treatment 3 completed NCT05645627
A Study to Evaluate IBI112 in the Treatment of Psoriasis With Moderate to Severe Plaque Psoriasis No drug interventions treatment 3 active_not_recruiting NCT02955576
Microneedle Patch for Psoriatic Plaques No drug interventions treatment Not Available unknown_status NCT01223976
Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis No drug interventions diagnostic 4 unknown_status NCT00006276
Micellar Paclitaxel to Treat Severe Psoriasis treatment 2 completed NCT06110676
A Study to Evaluate the Efficacy and Safety of LZM012 treatment 3 recruiting NCT00195676
Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis treatment 3 completed NCT00115076
Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT03827876
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis treatment 4 recruiting NCT04340076
Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis treatment 4 active_not_recruiting NCT01206660
Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT06402760
Comprehensive Intervention of Diabetes and Psoriasis Comorbidity Prevention and Control No drug interventions prevention 0 not_yet_recruiting NCT03587194
Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis treatment 4 completed NCT00992394
Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept treatment 4 completed NCT02652494
Observational Study of Apremilast in Patients With Psoriasis in The Netherlands No drug interventions Not Available Not Available completed NCT00134394
Etanercept With Tacrolimus for Psoriasis treatment 2 completed NCT00617994
Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis treatment 2 completed NCT01241591
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis treatment 3 completed NCT00477191
Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis prevention Not Available terminated NCT02574091
Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients treatment 1 completed NCT01947491
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis No drug interventions treatment 3 completed NCT00646191
Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis treatment 2 completed NCT05065762
Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment No drug interventions Not Available Not Available completed NCT00224562
The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists Not Available Not Available unknown_status NCT01096862
A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Psoriasis treatment 2 completed NCT00940862
Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis prevention 4 completed NCT03127462
A Nurse-led Individualized Educational Intervention No drug interventions supportive_care Not Available unknown_status NCT00687362
A Study to Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528) treatment 2 completed NCT01802580
Using an Internet Study to Improve Adherence for Psoriasis Patients treatment 0 completed NCT06156280
A Clinical Study of TQH2929 in Healthy Adult Subjects No drug interventions treatment 1 recruiting NCT02322580
An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients Not Available Not Available completed NCT00824980
Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis No drug interventions treatment 2 unknown_status NCT00789880
Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3 treatment 2 completed NCT02660580
MSB11022 in Moderate to Severe Chronic Plaque Psoriasis treatment 3 completed NCT04459780
Characterization and Functionality of Calcium Channels Cav1.4 of Th17 Lymphocytes in Human With Psoriasis No drug interventions basic_science Not Available completed NCT02330380
Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation Not Available Not Available completed NCT00096980
A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies treatment 4 completed NCT01352780
Psoriasis and Climate Therapy- Effect of Motivational Follow- up Calls on Clinical and Health Economic Parameters No drug interventions health_services_research 3 unknown_status NCT00230529
A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis treatment 2 completed NCT00147329
Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis treatment 2 completed NCT04914429
A Study of Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque Psoriasis treatment 4 completed NCT04776629
A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors treatment 2 completed NCT03082729
Vascular Inflammation in Psoriasis - Apremilast treatment 4 completed NCT04469829
Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome treatment 4 unknown_status NCT02362789
Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional Biomarkers treatment 3 completed NCT01519089
A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis treatment 3 completed NCT06448689
Analytical Validation of Wrist-Based Assessment of Nocturnal Scratch in Atopic Dermatitis and Psoriasis No drug interventions Not Available Not Available recruiting NCT01989689
Etanercept and Vascular Function in Psoriasis treatment 2 completed NCT00710489
Potential Research Study Participant Registry No drug interventions Not Available Not Available completed NCT00824889
Exploratory Study of Natural Killer Cells in Human Skin No drug interventions Not Available Not Available completed NCT02936492
BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study other 1 terminated NCT02155192
An Exploratory Genetic Study in Participants With Psoriasis No drug interventions Not Available Not Available completed NCT02173392
A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab treatment 1 completed NCT00645892
Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis treatment 2 completed NCT04250792
Efficacy of Low Dose Naltrexone in Psoriasis treatment 1 completed NCT00470392
Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis Not Available Not Available terminated NCT05601492
Adherence to Otezla other 0 not_yet_recruiting NCT04713592
Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement treatment 3 completed NCT01186744
A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis treatment 3 completed NCT03173144
Chronic Inflammatory Disease, Lifestyle and Treatment Response No drug interventions Not Available Not Available completed NCT01931644
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions No drug interventions Not Available Not Available completed NCT02624544
Proton Pump Inhibitors Use in Patients With Psoriasis treatment 4 withdrawn NCT01550744
A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis treatment 3 completed NCT05684744
Roflumilast Versus Methotrexate in Psoriasis treatment 2 / 3 completed NCT01714544
Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis treatment 4 completed NCT02207244
A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment treatment 3 completed NCT04581044
Impact of COVID-19 on Psoriasis Practice No drug interventions Not Available Not Available completed NCT02168244
Reduction of Pain Caused by Biologic Drugs in Psoriasis No drug interventions supportive_care Not Available completed NCT02346240
Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO) treatment 3 completed NCT00436540
A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam treatment 4 completed NCT02432040
Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis treatment 2 completed NCT00097240
An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW) No drug interventions Not Available Not Available completed NCT04271540
MIcrovascular dysfuNction In Moderate-severe Psoriasis treatment 4 active_not_recruiting NCT06170840
A Study of QY101 Ointment in Subjects With Plaque Psoriasis No drug interventions treatment 2 recruiting NCT05680740
A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis treatment 4 completed NCT01245140
Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis treatment 2 completed NCT04013867
Identification of the Best Self-questionnaire to Diagnose Depression in Patients With Psoriasis (DePsoVal) No drug interventions Not Available Not Available completed NCT01261767
First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerability and Early Signals of Biologic and Clinical Effects treatment 1 terminated NCT02394301
Efficacy of Novel Drug-combinations for Relief of Psoriasis No drug interventions Not Available Not Available suspended NCT02772601
This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis treatment 1 completed NCT00687401
A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612) treatment 3 completed NCT00454701
Assessment and Tracking of Long-term Alefacept Safety Not Available Not Available terminated NCT02630901
Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis No drug interventions treatment 1 completed NCT04912401
the Efficacy and Safety of Etanercept （Yi Sai Pu) in Chinese Patients With Moderate-to-Severe Psoriasis No drug interventions Not Available Not Available recruiting NCT05311501
Impact of Non-surgical Periodontal Therapy in the Management of Plaque Psoriasis. No drug interventions treatment Not Available unknown_status NCT01826201
Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis treatment 2 completed NCT03202004
GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis treatment 3 withdrawn NCT01356004
Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant Psoriasis No drug interventions treatment 4 completed NCT02635204
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis treatment 3 completed NCT01543204
Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab treatment 4 terminated NCT00763204
A Phase I Study to Assess Novel Cream in a Psoriasis Plaque Test treatment 1 completed NCT03423004
Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin No drug interventions basic_science Not Available completed NCT02310204
Therapeutic Education Program in Psoriasis No drug interventions supportive_care Not Available completed NCT02187172
Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U) treatment 4 completed NCT03721172
Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy treatment 3 completed NCT02785172
Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis treatment 2 completed NCT04246372
Tofacitinib for Immune Skin Conditions in Down Syndrome treatment 2 active_not_recruiting NCT02162472
Videocapillaroscopy Assessment During Systemic Agent Therapy in Psoriasis No drug interventions Not Available Not Available completed NCT02326272
A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) treatment 3 completed NCT02752672
Study on the Therapeutic Mechanisms of Dithranol Treatment in Patients With Chronic Plaque Psoriasis No drug interventions Not Available Not Available completed NCT00004468
Study of Topical Calcitriol or Oral Calcitriol in Patients With Psoriasis treatment Not Available withdrawn NCT01999868
Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris treatment 2 completed NCT04537468
Development of a Method to Measure mRNA Levels in Skin Samples No drug interventions other Not Available completed NCT00995969
CT 327 in the Treatment of Psoriasis Vulgaris treatment 2 completed NCT02763969
Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis treatment 1 completed NCT05928169
Determinants of Chronic Inflammatory Skin Disease Trajectories No drug interventions Not Available Not Available recruiting NCT01967069
A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis No drug interventions treatment 3 completed NCT03493269
A Multiple Dose Study of BAY1834845 in Healthy Male Subjects and in Patients With Psoriasis treatment 1 completed NCT00267969
A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis treatment 3 completed NCT01778569
The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI) No drug interventions Not Available Not Available completed NCT01971346
The Immunological Basis for Treatment Resistance to Anti-TNF Treatments treatment 4 completed NCT01451346
Study in Patients With Mild to Moderate Psoriasis No drug interventions treatment 1 / 2 completed NCT03084146
The Role of Food Sensitivity in Psoriasis No drug interventions other Not Available completed NCT03831646
Clinical, Psychological and Genetic Characteristics in Dermatological Patients No drug interventions Not Available Not Available completed NCT03570346
Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects No drug interventions treatment 1 unknown_status NCT00537212
Study of the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy No drug interventions treatment Not Available completed NCT05135312
Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging treatment 4 unknown_status NCT02934412
A Study of SHR-1314 in Healthy Subjects other 1 completed NCT00678210
Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis treatment 2 completed NCT03007810
Safety and Pharmacokinetics of Hemay005 In Healthy Male Subjects No drug interventions treatment 1 completed NCT02382081
A Randomized Control Trial of Patient-initiated Hospital Follow-up for Patients With Psoriasis No drug interventions supportive_care Not Available completed NCT03835481
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is No drug interventions treatment 2 terminated NCT02054481
BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab treatment 2 completed NCT01121081
The Effect of Algae Dunaliella Bardawil on Psoriasis (2) No drug interventions treatment 3 withdrawn NCT02983981
Topical Psoriasis Study for Patients Receiving Biologic Therapy treatment 4 completed NCT04927195
Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma No drug interventions treatment 1 completed NCT00686595
A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133) treatment 4 completed NCT04975295
A Study of LY3361237 in Participants With Psoriasis basic_science 1 completed NCT01008995
A Study of the Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With Psoriasis treatment 3 completed NCT06103695
Vtama in Psoriasis Patients Being Treated With Biologics. treatment 4 completed NCT03047395
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) treatment 3 completed NCT06324695
Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases No drug interventions prevention Not Available not_yet_recruiting NCT04136314
Impact of Decision-Framing in Psoriasis No drug interventions health_services_research Not Available completed NCT03626714
Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study treatment 0 completed NCT05513014
Impact of Secukinumab on Clinical and Patient Reported Outcomes in Patients With Psoriasis Not Available Not Available completed NCT00823914
Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life No drug interventions Not Available Not Available completed NCT01722214
Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis prevention 4 completed NCT00669214
A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp treatment 4 completed NCT00161655
Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis treatment 4 completed NCT03340155
Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases No drug interventions other Not Available unknown_status NCT00581555
Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy treatment 4 completed NCT05570955
Deucravacitinib Adherence Study No drug interventions other Not Available recruiting NCT01899755
A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects. treatment 1 completed NCT00848055
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of AbGn-168 in Psoriasis No drug interventions treatment 1 completed NCT00820950
A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis treatment 2 completed NCT01577550
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis treatment 1 completed NCT00708708
Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care Settings Not Available Not Available completed NCT03399708
Immune Metabolic Associations in Psoriatic Arthritis Not Available Not Available completed NCT00249808
A Study of Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies treatment 4 completed NCT04967508
A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT03875508
A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis treatment 3 completed NCT05258838
Tunisian National Registry on Psoriasis No drug interventions Not Available Not Available recruiting NCT03889938
Serum Level of Bioactive Mediators and Urinary Biopyrins in Psoriasis No drug interventions Not Available Not Available unknown_status NCT00967538
Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments treatment 4 completed NCT02489643
Individualized Medical Training and Calcipotriol and Betamethasone Dipropionate Gel in Plaque Psoriasis No drug interventions treatment Not Available completed NCT01462643
Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque Test No drug interventions treatment 2 completed NCT01047943
STA-21 Topical Efficacy on Psoriasis treatment 1 / 2 completed NCT00338143
A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies treatment 3 completed NCT02555826
Study of the Efficacy and Safety Of Apremilast (CC-10004), in Subjects With Moderate Plaque Psoriasis treatment 4 recruiting NCT02538757
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE) prevention 2 active_not_recruiting